Xiaoliang Shi

Polyendocrine metabolic ovarian syndrome (PMOS, formerly Polycystic Ovary Syndrome): a systems-biology perspective on neuroendocrine, immuno-metabolic and epigenetic mechanisms across the life course

Polyendocrine metabolic ovarian syndrome (PMOS) is the name adopted in 2026 by the Global Name Change Consortium for the condition previously called polycystic ovary syndrome (PCOS); diagnostic criteria are unchanged, and a managed three-year transition to the new terminology is...